BOARD OF DIRECTORS

The N2 Board of Directors consists of 10 individuals representing from across Canada.

Jim Pankovich

Jim Pankovich

Chair

Executive Vice President, Clinical Development, Bold Therapeutics Inc

Rachel Syme

Rachel Syme

Vice Chair

N2 Board Member
N2 Vice Chair
Program Director, Research, Cystic Fibrosis Canada

Patrick Clifford

Patrick Clifford

Treasurer

N2 Board Member
N2 Treasurer

Erin Cherban

Erin Cherban

Secretary

Chief Clinical Research Officer for Advancing Health and the CIHR Canadian HIV Trials Network (CTN)

 

Daniela M. Bianco

Daniela M. Bianco

Board Member

Manager, Research Development & Relations, Hamilton Health Sciences

Kathy Brodeur-Robb

Kathy Brodeur-Robb

Board Member

Executive Director C-17 Council

Jennifer Li

Jennifer Li

Board Member

Quality Manager, Cancer Clinical Research Unit, Princess Margaret Cancer Centre – University Health Network

Tammy Mah-Fraser

Tammy Mah-Fraser

Board Member

Executive Director, Health Platforms, Alberta Innovates

Janette Panhuis

Janette Panhuis

Board Member

N2 Board Member

Jordan Warford

Jordan Warford

Senior Director of Research for Nova Scotia Health

N2 Board Member